The emerging role of the interferon-induced PKR protein kinase as an apoptotic effector: A new face of death?

Journal of Interferon and Cytokine Research

Volumn 19, Issue 6, 1999, Pages 543-554

  Tan, Seng Lai ^a   Katze, Michael G ^a,b,c  

^a Seattle Children's Hospital   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; INTERFERON; PROTEIN KINASE; PROTEIN SERINE KINASE; THREONINE;

ANTIVIRAL ACTIVITY; APOPTOSIS; CANCER INHIBITION; CELL DEATH; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; MOLECULAR DYNAMICS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; VIRUS INFECTION;

ANIMALS; APOPTOSIS; CELL DEATH; EIF-2 KINASE; ENZYME INDUCTION; GENES, TUMOR SUPPRESSOR; HUMANS; INTERFERONS; VIRUSES;

EID: 0032811002     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099313677     Document Type: Review

References (121)

1. SCHWARTZ, L.M., and OSBORNE, B.A. (1993). Programmed cell death, apoptosis and killer genes. Immonol. Today 14, 582-590.
2. STELLER, H. (1995). Mechanisms and genes of cellular suicide. Science 267, 1445-1449.
3. ZOU, H., HENZEL, W.J., LIU, X.S., LUTSCHG, A., and WANG, X.D. (1997). Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90, 405-413.
4. MILLER, L.K. (1997). Baculovirus interaction with host apoptotic pathways. J. Cell. Physiol. 173, 178-182.
5. TEODORO, J.G. and BRANTON, P.E. (1997). Regulation of apoptosis by viral gene products. J. Virol. 71, 1739-1746.
6. GILLET, G., and BRUN, G. (1996). Viral inhibition of apoptosis. Trends Microbiol. 4, 312-317.
7. PROUD, C.G. (1995). PKR: a new name and new roles. Trends Biochem. Sci. 20, 241-246.
8. KOROMILAS, A.E., CANTIN, C., CRAIG, A.W., JAGUS, R., HISCOTT, J., and SONENBERG, N. (1995). The inierferon-inducible protein kinase PKR modulates the transcriptional activation of immunoglobulin kappa gene. J. Biol. Chem. 270, 25426-25434.
9. MUNDSCHAU, L.J., and FALLER, D.V. (1995). Platelet-derived growth factor signal transduction through the interferon-inducible kinase PKR. Immediate early gene induction. J. Biol. Chem. 270, 3100-3106.
10. SALZBERG, S., MANDELBOIM, M., ZALCBERG, M., SHAINBERG, A., and MANDELBAUM, M. (1995). Interruption of myogenesis by transforming growth factor beta 1 or EGTA inhibits expression and activity of the myogenic-associated (2′-5′) oligoadenylate synthetase and PKR. Exp. Cell. Res. 219, 223-232.
11. WILLIAMS, B.R.G. (1995). The role of the dsRNA-activated kinase, PKR, in signal transduction. Semin. Virol. 6, 191-202.
12. LENGYEL, P. (1993). Tumor-suppressor genes: news about the interferon connection. Proc. Natl. Acad. Sci. USA. 90, 5893-5895.
13. CLEMENS, M.J., and ELIA, A. (1997). The double-stranded RNA-dependent protein kinase PKR: Structure and function. J. Interferon Cytokine Res. 17, 503-524.
14. GALE, M., Jr., and KATZE, M.G. (1998). Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol. Ther. 78, 29-16.
15. MEURS, E., CHONG, K., GALABRU, J., THOMAS, M.S., KERR, I.M., WILLIAMS, B.R.G., and HOVANESSIAN, A.G. (1990). Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62, 379-390.
16. WU, S., and KAUFMAN, R.J. (1996). Double-stranded (ds) RNA binding and not dimerization correlates with the activation of the dsRNA-dependent protein kinase (PKR). J. Biol. Chem. 271, 1756-1763.
17. CARPICK, B.W., GRAZIANO, V., SCHNEIDER, D., MAITRA, R.K., LEE, X., and WILLIAMS, B.R.G. (1997). Characterization of the solution complex between the interferon-induced, double-stranded RNA-activated protein kinase and HIV-I TAR RNA. J. Biol. Chem. 272, 9510-9516.
18. IPK inhibitor. Mol. Cell. Biol. 18, 2431-2443.
19. THOMAS, D.C., and SAMUEL, C.E. (1993). Mechanism of interferon action: evidence for intermolecular autophosphorylation and autoactivation of the interferon-induced, RNA-dependent protein kinase PKR. J. Virol. 67, 7695-700.
20. HOVANESSIAN, A.G., and GALABRU, J. (1987). The double-stranded RNA-dependent protein kinase is also activated by heparin. Eur. J. Biochem. 167, 467-473.
21. YEUNG, M.C., LIU, J., and LAU, A.S. (1996). An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor decrosis factor-induced apoptosis in U937 cells. Proc. Natl Acad. Sci. USA 93, 12451-12455.
22. PROSTKO, C.R., DHOLAKIA, J.B., BROSTROM, M.A., and BROSTROM, C.O. (1995). Activation of the double-stranded RNA-regulated protein kinase by depletion of endoplasmic reticular calcium stores. J. Biol. Chem. 270, 6211-6215.
23. 2+ stores, phosphorylation of eIF2α, and sustained inhibition of translation initiation mediate the anticancer effects of clotrimozole. Proc. Natl. Acad. Sci. USA 95, 8280-8285.
24. GUSELLA, G.L., MUSSO, T., ROTTSCHAFER, S.E., PULKKI, K., and VARESIO, L. (1995). Potential requirement of a functional double-stranded RNA-dependent protein kinase (PKR) for the tumoricidal activation of macrophages by lipopolysaccharide of IFN-α, -β, but not IFN-γ. J. Immunol. 154, 345-354.
25. SAMUEL, C.E. (1993). The eIF-2α protein kinases, regulators of translation in eukaryotes from yeasts to humans. J. Biol. Chem. 268, 7603-7606.
26. KUMAR, A., HAQUE, J., LACOSTE, J., HISCOTT, J., and WILLIAMS, B.R.G. (1994). Double-stranded RNA-dependent protein kinase activates transcription factor NFκB by phosphorylating IκB. Proc. Natl. Acad. Sci. USA 91, 6288-6292.
27. GALABRU, J., and HOVANESSIAN, A. (1987). Autophosphorylation of the protein kinase dependent on double-stranded RNA. J. Biol. Chem. 262, 15538-15544.
28. RICE, A.P., KOSTURA, M., and MATHEWS, M.B. (1989). Identification of a 90-kDa polypeptide which associates with adenovirus VA RNAI and is phosphorylated by the double-stranded RNA-dependent protein kinase. J. Biol. Chem. 264, 20632-20637.
29. MATHEWS, M.B. (1996). Interactions between viruses and the cellular machinery for protein synthesis. In: Translational Control J. Hershey, M. Mathews, and N. Sonenberg, (eds.) Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, pp. 505-548.
30. PETRYSHYN, R., CHEN, J.J., and LONDON, I.M. (1988). Detection of activated double-stranded RNA-dependent protein kinase in 3T3-F442A cells. Proc. Natl. Acad. Sci. USA. 85, 1427-1431.
31. BARBER, G.N., TOMITA, J., GARFINKEL, M.S., MEURS, E., HOVANESSIAN, A., and KATZE, M.G. (1992). Detection of protein kinase homologues and viral RNA-binding domains utilizing polyclonal antiserum prepared against a baculovirus-expressed dsRNA-activated 68,000-Da protein kinase. Virology 191, 670-679.
32. CHONG, K.L., FENG, L., SCHAPPERT, K., MEURS, E., DONAHUE, T.F., FRIESEN, J.D., HOVANESSIAN, A.G., and WILLIAMS, B.R.G. (1992). Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. EMBO J. 11, 1553-1562.
33. MEURS, E., GALABRU, J., BARBER, G.N., KATZE, M.G., and HOVANESSIAN, A.G. (1993). Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA. 90, 232-236.
34. KOROMILAS, A.E., ROY, S., BARBER, G.N., KATZE, M.G., and SONENBERG, N. (1992). Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257, 1685-1689.
35. BARBER, G.N., WAMBACH, M., THOMPSON, S., JAGUS, R., and KATZE, M.G. (1995). Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation. Mol. Cell. Biol. 15, 3138-3146.
36. BARBER, G.N., JAGUS, R., MEURS, E.F., HOVANESSIAN, A.G., and KATZE, M.G. (1995). Molecular mechanisms responsible for malignant transformation by regulatory and catalytic domain variants of the interferon-induced enzyme RNA-dependent protein kinase. J. Biol. Chem. 270, 17423-17428.
37. BARBER, G.N., THOMPSON, S., LEE, T.G., STROM, T., JAGUS, R., DARVEAU, A., and KATZE, M.G. (1994). The 58-kilodalton inhibitor of the interferon-induced double-stranded RNA-activated protein kinase is a tetratricopeptide repeat protein with oncogenic potential. Proc. Natl. Acad. Sci. USA 91, 4278-4282.
38. BENKIRANE, M., NEUVEUT, C., CHUN, R.F., SMITH, S.M., SAMUEL, C.E., GATIGNOL, A., and JEANG, K.T. (1997). Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR. EMBO J. 16, 611-624.
39. DONZ'E, O., JAGUS, R., KOROMILAS, A.E., HERSHEY, J.W., and SONENBERG, N. (1995). Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J. 14, 3828-3834.
40. SONENBERG, N. (1994). mRNA translation: influence of the 5′ and 3′ untranslated regions. Curr. Opin. Genet. Dev. 4, 310-315.
41. KORTH, M.J., and KATZE, M.G. (1997). mRNA metabolism and cancer. In: mRNA Metabolism and Post-transcriptional Gene Regulation. J.B. Harford and D.R. Morris, (eds.), New York: Wiley-Liss, Inc., pp. 265-280.
42. GEBALLE, A.P., and MORRIS, D.R. (1994). Initiation codons within 5′-leaders of mRNAs as regulators of translation. Trends Biochem. Sci. 19, 159-164.
43. KUMAR, A., YANG, Y.L., FLATI, V., DER, S., KADEREIT, S., DEB, A., HAQUE, J., REIS, L., WEISSMANN, C., and WILLIAMS, B.R.G. (1997). Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: Role of IRF-1 and NFκB. EMBO J. 16, 406-416.
44. YANG, Y.L., REIS, L.F.L., PAVLOVIC, J., AGUZZI, A., SCHAFER, R., KUMAR, A., WILLIAMS, B.R.G., AGUET, M., and WEISSMANN, C.M. (1995). Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 14, 6095-6106.
45. WONG, A.H., TAM, N.W., YANG, Y.L., CUDDIHY, A.R., LI, S., KIRCHHOFF, S., HAUSER, H., DECKER, T., and KOROMILAS, A.E. (1997). Physical-association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways. EMBO J. 16, 1291-1304.
46. KIRCHHOFF, S., KOROMILAS, A.E., SCHAPER, F., GRASHOFF, M., SONENBERG, N., and HAUSER, H. (1995). IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR. Oncogene 11, 439-445.
47. BERETTA, L., GABBAY, M., BERGER, R., HANASH, S.M., and SONENBERG, N. (1996). Expression of the protein kinase PKR is modulated by IRF-1 and is reduced in 5q-associated leukemias. Oncogene 12, 1593-1596.
48. NGUYEN, H., LIN, R., and HISCOTT, J. (1997). Activation of multiple growth regulatory genes following inducible expression of IRF-1 or IRF/RelA fusion proteins. Oncogene 15, 1425-1435.
49. DAVIS, S., and WATSON, J.C. (1996). In vitro activation of the interferon-induced, double-stranded RNA-dependent protein kinase PKR by RNA from the 3′ untranslated regions of human alpha-tropomyosin. Proc. Natl. Acad. Sci. USA 93, 508-513.
50. SIDHU, G.S., SINGH, A.K., RAGHUNATH, P.N., SIVARAM, S., and MAHESHWARI, R.K. (1996). Brefeldin A inhibits the antiviral action of interferon against encephalomyocarditis virus. Virus Res. 40, 123-133.
51. HAINES, G.K., GHADGE, G.D., BECKER, S., KIES, M., PELZER, H., THIMMAPPAYA, B., and RADOSEVICH, J.A. (1993). Correlation of the expression of double-stranded RNA-dependent protein kinase (p68) with differentiation in head and neck squamous cell carcinoma. Virchows Arch. B-Cell. Pathol. Incl. Mol. Pathol. 63, 289-295.
52. HAINES, G.K., BECKER, S., GHADGE, G., KIES, M., PELZER, H., and RADOSEVICH, J.A. (1993). Expression of the double-stranded RNA-dependent protein kinase (p68) in squamous cell carcinoma of the head and neck region. Arch. Otolaryngol. Head-Neck Surg. 119, 1142-1147.
53. HAINES, G.K., PANOS, R.J., BAK, P.M., BROWN, T., ZIELINSKI, M., LEYLAND, J., and RADOSEVICH, J.A. (1998). Interferon-responsive protein kinase (p68) and proliferating cell nuclear antigen are inversely distributed in head and neck squamous cell carcinoma. Tumour Biol. 19, 52-59.
54. HAINES, G.K., GHADGE, G., THIMMAPPAYA, B., and RADOSEVICH, J.A. (1992). Expression of the protein kinase p-68 recognized by the monoclonal antibody TJ4C4 in human lung neoplasms. Virchows Arch. B-Cell Pathol. Incl. Mol. Pathol. 62, 151-158.
55. SINGH, C., HAINES, G.K., TALAMONTI, M.S., and RADOSEVICH, J.A. (1997). Expression of p68 in human colon cancer. Tumour Biol. 16, 281-289.
56. HAINES, G.K., CAJULIS, R., HAYDEN, R., DUDA, R., TALAMONTI, M., and RADOSEVICH, J.A. (1996). Expression of the double-stranded RNA-dependent protein kinase (p68) in human breast tissues. Tumour Biol. 17, 5-12.
57. THOMIS, D.C., and SAMUEL, C.E. (1992). Mechanism of interferon action: autoregulation of RNA-dependent P1/eIF-2 alpha protein kinase (PKR) expression in transfected mammalian cells. Proc. Natl. Acad. Sci. USA 89, 10837-10841.
58. BARBER, G.N., WAMBACH, M., WONG, M.L., DEVER, T.E., HINNEBUSCH, A.G., and KATZE, M.G. (1993). Translational regulation by the interferon-induced double-stranded-RNA-activated 68-kDa protein kinase. Proc. Natl. Acad. Sci. USA 90, 4621-4625.
59. GALE, M. JR., KORTH, M.J., TANG, N.M., TAN, S-L., HOPKINS, D.A., DEVER, T.E., POLYAK, S.J., GRETCH, D.R., and KATZE, M.G. (1997). Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230, 217-227.
60. KAWAGISHI-KOBAYASHI, M., SILVERMAN, J.B., UNG, T.L., and DEVER, T.E. (1997). Regulation of the protein kinase PKR by the vaccinia virus pseudosubstrate inhibitor K3L is dependent on residues conserved between the K3L protein and the PKR substrate eIF2α. Mol. Cell. Biol. 17, 4146-4158.
61. DEVER, T.E., SRIPRIYA, R., MCLACHLIN, J.R., LU, J., FABIAN, J.R., KIMBALL, S.R., and MILLER, L.K. (1998). Disruption of cellular translational control by a viral truncated eukaryotic translation initiation factor 2α kinase homolog. Proc. Natl. Acad. Sci. USA 95, 4164-4169.
62. SHI, Y.G., VATTEM, K.M., SOOD, R., AN, J., LIANG, J.D., STRAMM, L., and WEK, R.C. (1998). Identification and characterization of pancreatic eukaryotic initiation factor 2α-subunit kinase. PEK, involved in translational control. Mol. Cell. Biol. 18, 7499-7509.
63. BARBER, G.N., EDELHOFF, S., KATZE, M.G., and DISTECHE, C. (1993). Chromosomal assignment of the interferon-inducible double-stranded RNA-dependent protein kinase (PKR) to human chromosome 2p21-p22 and mouse chromosome 17 E2. Genomics 16, 765-767.
64. SQUIRE, J., MEURS, E.F., CHONG, K.L., MCMILLAN, N.A., HOVANESSIAN, A.G., and WILLIAMS, B.R. (1993). Localization of the human interferon-induced, ds-RNA activated p68 kinase gene (PRKR) to chromosome 2p21-p22. Genomics 16, 768-770.
65. ABRAHAM, N., JARAMILLO, M.L., DUNCAN, P.I., METHOT, N., ICELY, P.L., STOJDL, D.F., BARBER, G.N., and BELL, J.C. (1998). The murine PKR tumor suppressor gene is rearranged in a lymphocytic leukemia. Experimental Cell Res. 244, 394-104.
66. LEE, S.B., and ESTEBAN, M. (1994). The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology 199, 491-496.
67. LEE, S.B., RODRIGUEZ, D., RODRIGUEZ, J.R., and ESTEBAN, M, (1997). The apoptosis pathway triggered by the interferon-induced protein kinase PKR requires the third basic domain, initiates upstream of Bcl-2, and involves ICE-like proteases. Virology 231, 81-88.
68. SRIVASTAVA, S.P., KUMAR, K.U., and KAUFMAN, R.J. (1998). Phosphorylation of eukaryotic translation initiation factor 2 mediates apoptosis in response to activation of the double-stranded RNA-dependent protein kinase. J. Biol. Chem. 273, 2416-2423.
69. BALACHANDRAN, S., KIM, C.N., YEH, W-C., MAK, T.K., BHALLA, K., and BARBER, G.N. Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J. 17, 6888-6902.
70. TAKIZAWA, T. OHASHI, K., and NAKANISHI, Y. (1996). Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection. J. Virol. 70, 8128-8132.
71. DER, S.D., YANG, Y.L., WEISSMANN, C., and WILLIAMS, B.R.G. (1997). A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc. Natl. Acad. Sci. USA 94, 3279-3283.
72. DEGRACIA, D.J., SULLIVAN, J.M., NEUMAR, R.W., ALOUSI, S.S., HIKADE, K.R., PITTMAN, J.E., WHITE, B.C., RAFOLS, J.A., and KRAUSE, G.S. (1997). Effect of brain ischemia and reperfusion on the localization of phosphorylated eukaryotic initiation factor 2α. J. Cerebral Blood Flow Metab. 17, 1291-1302.
73. 2+ ionophore-treated cultured neuronal cells. Neurosci. Lett. 201, 215-218.
74. ALCAZAR, A., DELAVEGA, C.M., BAZAN, E., FANDO, J.L., and SALINAS, M. (1997). Calcium mobilization by ryanodine promotes the phosphorylation of initiation factor 2α subunit and inhibits protein synthesis in cultured neurons. J. Neurochem. 69, 1703-1708.
75. ITO, T., JAGUS, R., and MAY, W.S. (1994). Interleukin 3 stimulates protein synthesis by regulating double-stranded RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA 91, 7455-7459.
76. MARTIN, S.J., BONHAM, A.M., and COTTER, T.G. (1990). The involvement of RNA and protein synthesis in programmed cell death (apoptosis) in human leukaemia HL-60 cells. Biochem. Soc. Trans. 18, 634-636.
77. WARING, P. (1990). DNA fragmentation induced in macrophages by gliotoxin does not require protein synthesis and is preceded by raised inositol triphosphate levels. J. Biol. Chem. 265, 14476-14480.
78. DECKWERTH, T.L., and JOHNSON, E.M., JR. (1993). Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J. Cell Biol. 123, 1207-1222.
79. LOCKSHIN, R.A., and ZAKERI, Z. (1994). Programmed cell death: early changes in metamorphosing cells. Biochem. Cell. Biol. 72, 589-596.
80. SCHWARTZMAN, R.A., and CIDLOWSKI, J.A. (1993). Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr. Rev. 14, 133-151.
81. POLUNOVSKY, V.A., ROSENWALD, I.B., TAN, A.T., WHITE, J., CHIANG, L., SONENBERG, N., and BITTERMAN, P.B. (1996). Translational control of programmed cell death: Eukaryotic translation initiation factor 4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated Myc. Mol. Cell. Biol. 16, 6573-6581.
82. MARTIN, S.J., and GREEN, D.R. (1995). Apoptosis and cancer: the failure of controls on cell death and cell survival. Crit. Rev. Oncol. Hematol. 18, 137-153.
83. DIAZGUERRA, M., RIVAS, C., and ESTEBAN, M. (1997). Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells. Virology 236, 354-363.
84. HINNEBUSCH, A.G. (1997). Translational regulation of yeast GCN4 - A window on factors that control initiator-tRNA binding to the ribosome. J. Biol. Chem. 272, 21661-21664.
85. COHEN, G.M. (1997). Caspases: the executioners of apoptosis. Biochem. J. 326, 1-16.
86. NAGATA, S., and GOLSTEIN, P. (1995). The Fas death factor. Science 267, 1449-1456.
87. GREEN, D.R., and REED, J.C. (1998). Mitochondira and apoptosis. Science 281, 1309-1312.
88. SONENSHEIN, G.E. (1997). Rel/NF-kappa B transcription factors and the control of apoptosis. Semin. Cancer Biol. 8, 113-119.
89. YEUNG, M.C., and LAU, A.S. (1998). Tumor suppressor p53 as a component of the tumor necrosis factor-induced, protein kinase PKR-mediated apoptotic pathway in human promonocytic U937 cells. J. Biol. Chem. 273, 25198-25202.
90. MIYASHITA, T., and REED, J.C. (1995). Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299.
91. BRUN, A., RIVAS, C., ESTEBAN, M., ESCRIBANO, J.M., and ALONSO, C. (1996). African swine fever virus gene A179L, a viral homologue of bcl-2, protects cells from programmed cell death. Virology 225, 227-230.
92. GUO, H., TITTLE, T.V., ALLEN, H., and MAZIARZ, R.T. (1998). Brefeldin A-mediated apoptosis requires the activation of caspases and is inhibited by Bcl-2. Exp. Cell Res. 245, 57-68.
93. BEATTIE, E., KAUFFMAN, E.B., MARTINEZ, H., PERKUS, M.E., JACOBS, B.L., PAOLETTI, E., and TARTAGLIA, J. (1996). Host-range restriction of vaccinia virus E3L-specific deletion mutants. Virus Genes 12, 89-94.
94. KIBLER, K.V., SHORS, T., PERKINS, K.B., ZEMAN, C.C., BANASZAK, M.P., BIESTERFELDT, J., LANGLAND, J.O., and JACOBS, B.L. (1997). Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. J. Virol. 71, 1992-2003.
95. LANGLAND, J.O., PETTIFORD, S., JIANG, B., and JACOBS, B.L. (1994). Products of porcine group C rotavirus NSP3 gene bind specifically to double-stranded RNA and inhibit activation of the interferon-induced protein kinase PKR. J. Virol. 68, 3821-3829.
96. BEATTIE, E., DENZLER, K.L., TARTAGLIA, J., PERKUS, ME., PAOLETTI, E. and JACOBS, B.L. (1995). Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. J. Virol. 69, 499-505.
97. PARK, H., DAVIES, M.V., LANGLAND, J.O., CHANG, H.W., NAM, Y.S., TARTAGLIA, J., PAOLETTI, E., JACOBS, B.L., KAUFMAN, R.J., and VENKATESAN, S. (1994). TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR. Proc. Natl. Acad. Sci. USA 91, 4713-4717.
98. HE, B., GROSS, M., and ROIZMAN, B. (1997). The γ(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1 alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 94, 843-848.
99. CHOU, J., and ROIZMAN, B. (1990). The herpes simplex virus 1 gene for ICP34.5, which maps in inverted repeats, is conserved in several limited-passage isolates but not in strain 17syn+. J. Virol. 64, 1014-1020.
100. 1(34.5) gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programmed cell death in neuronal cells. Proc. Natl. Acad. Sci. USA 89, 3266-3270.
101. 1(34.5)- mutants of herpes simplex virus 1. Proc. Nail. Acad. Sci. USA 92, 10516-10520.
102. KIGUCHI, K., GLESNE, D., CHUBB, C.H., FUJIKI, H., and HUBERMAN, E. (1994). Differential induction of apoptosis in human breast tumor cells by okadaic acid and related inhibitors of protein phosphatases 1 and 2A. Cell. Growth Differ. 5, 995-1004.
103. KAWAMURA, T., MATSUZAWA, S., MIZUNO, Y., KIKUCHI, K., OIKAWA, H., OIKAWA, M., UBUKATA, M., and ICHIHARA, A. (1998). Different moieties of tautomycin involved in protein phosphatase inhibition and induction of apoptosis. Biochem. Pharmacol. 55, 995-1003.
104. INOMATA, M., SAIJO, N., KAWASHIMA, K., KANEKO, A., FUJIWARA, Y., KUNIKANE, H., and TANAKA, Y. (1995). Induction of apoptosis in cultured retinoblastoma cells by the protein phosphatase inhibitor, okadaic acid. J. Cancer Res. Clin. Oncol. 121, 729-738.
105. MESNER, P.W., WINTERS, T.R., and GREEN, S.H. (1992). Nerve growth factor withdrawal-induced cell death in neuronal PC12 cells resembles that in sympathetic neurons. J. Cell Biol. 119, 1669-1680.
106. TAN, S-L., MELVILLE, M.W., and KATZE, M.G. Unpublished data.
107. SZYSZKA, R., KUDLICKI, W., KRAMER, G., HARDESTY, B., GALABRU, J., and HOVANESSIAN, A. (1989). A type 1-phosphoprotein phosphatase active with phosphorylated Mr = 68,000 initiation factor 2 kinase. J. Biol. Chem. 264, 3827-3831.
108. WEK, R.C., CANNON, J.F., DEVER, T.E., and HINNEBUSCH, A.G. (1992). Truncated protein phosphatase GLC7 restores translational activation of GCN4 expression in yeast mutants defective for the eIF-2α kinase GCN2. Mol. Cell. Biol. 12, 5700-5710.
109. REDPATH, N.T., and PROUD, C.G. (1990). Activity of protein phosphatases against initiation factor-2 and elongation factor-2. Biochem. J. 272, 175-180.
110. IPK, the cellular inhibitor of PKR. Proc. Natl. Acad. Sci. USA 94, 97-102.
111. LU, Y., WAMBACH, M., KATZE, M.G., and KRUG, R.M. (1995). Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the eIF-2 translation initiation factor. Virology 214, 222-228.
112. IPK and vaccinia virus K3L is mediated by unique domains: Implications for kinase regulation. Mol. Cell. Biol. 16, 4172-4181.
113. TAN, S-L. and KATZE, M.G. (1998). Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase. J. Interferon Cytokine Res. 18, 757-766.
114. IPK. Mol Cell. Biol. In press.
115. SCHULTZ-CHERRY, S., KRUG, R.M., and HINSHAW, V.S. (1998). Induction of Apoptosis by Influenza Virus. Semin. Virol. 8, 491-495.
116. PATEL, R.C., and SEN, G.C. (1998). PACT, a protein activator of the interferon-induced protein kinase, PKR. EMBO J. 17, 4379-4390.
117. VOJDANI, A., GHONEUM, M., CHOPPA, P.C., MAGTOTO, L., and LAPP, C.W. (1997). Elevated apoptotic cell population in patients with chronic fatigue syndrome: the pivotal role of protein kinase RNA. J. Int. Medicine 242, 465-478.
118. ZAMANIAN-DARYOUSH, M., DER, S.D., and WILLIAMS, B.R.G. (1999). Cell cycle regulation of the double stranded RNA activated protein kinase, PKR. Oncogene 18, 315-326.
119. THOMPSON, C.B. (1995). Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462.
120. FAVROT, M., COLL, J.L., LOUIS, N., and NEGOESCU, A. (1998). Cell death and cancer: replacement of apoptotic genes and inactivation of death suppressor genes in therapy. Gene Therapy 5, 728-739.
121. DONZE, O., DOSTIE, J., and SONENBERG, N. (1999). Regulatable expression of the interferon-induced double-stranded RNA dependent protein kinase PKR induces apoptosis and Fas receptor expression. Virology 256, 322-329.